HealthStream, Inc. (HSTM) Q4 2025 Earnings Call Transcript
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 24 2026
0mins
Should l Buy HSTM?
Source: SeekingAlpha
Full Year 2025 Revenue Revenues up 4.3% year-over-year. Growth attributed to strong performance in subscription products and new acquisitions.
Full Year 2025 Adjusted EBITDA Adjusted EBITDA up 7.5% year-over-year. Increase driven by operational efficiencies and revenue growth.
Fourth Quarter 2025 Revenue Revenues up 7.4% year-over-year. Growth supported by strong subscription product performance and acquisitions.
Fourth Quarter 2025 Adjusted EBITDA Adjusted EBITDA up 16.4% year-over-year. Growth attributed to increased subscription revenues and operational improvements.
Fourth Quarter 2025 Operating Income Operating income down 48.8% year-over-year. Decline due to non-cash compensation expense from CEO stock grant and acquisition-related costs.
Fourth Quarter 2025 Net Income Net income down 48.1% year-over-year. Decline influenced by non-cash compensation expense and acquisition-related costs.
Fourth Quarter 2025 Non-GAAP Operating Income Non-GAAP operating income up 31.7% year-over-year. Increase due to adjustments excluding CEO stock grant impact.
Fourth Quarter 2025 Non-GAAP Net Income Non-GAAP net income up 9.5% year-over-year. Growth driven by adjustments excluding CEO stock grant impact.
Fourth Quarter 2025 Subscription Revenue Subscription revenues up 8.2% year-over-year. Growth driven by CredentialStream (21%), ShiftWizard (31%), and Competency Suite (27%).
Fourth Quarter 2025 Professional Services Revenue Professional services revenues down 11.6% year-over-year. Decline attributed to reduced demand for legacy services.
CredentialStream Revenue (Q4 2025) Revenue up 21% year-over-year. Growth driven by conversions from legacy products and new customer acquisitions.
ShiftWizard Revenue (Q4 2025) Revenue up 31% year-over-year. Growth attributed to health care-specific advantages and customer demand.
Competency Suite Revenue (Q4 2025) Revenue up 27% year-over-year. Growth supported by strong customer adoption and bundled sales.
Free Cash Flow (Full Year 2025) Free cash flow up 5.5% year-over-year. Increase driven by higher cash flows from operations.
Capital Expenditures (Full Year 2025) Capital expenditures up 14.3% year-over-year. Increase due to investments in product development and infrastructure.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HSTM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HSTM
Wall Street analysts forecast HSTM stock price to rise
4 Analyst Rating
2 Buy
2 Hold
0 Sell
Moderate Buy
Current: 21.340
Low
25.00
Averages
25.00
High
25.00
Current: 21.340
Low
25.00
Averages
25.00
High
25.00
About HSTM
HealthStream, Inc. provides platform-delivered workforce solutions. Its solutions include Software-as-a-Service (SaaS), subscription-based applications used by healthcare organizations to meet a range of their workforce development needs around learning, clinical development, credentialing, and scheduling. Its content libraries allow customers to subscribe to an array of courseware, which includes content from healthcare and nursing associations, medical and healthcare publishers, and other content providers. Its scheduling solutions provide customers with real-time visibility into clinical staff scheduling. Its credentialing, privileging, and enrollment solution, CredentialStream, provides customers a user experience with a continual stream of enhancements, evidence-based content, and curated data, which provides healthcare organizations with tools to support the provider lifecycle management from recruiting, application submission, verification of licensure, and other credentials.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
HealthStream Schedules Q1 2026 Earnings Call and Webcast
- Earnings Release Schedule: HealthStream will release its Q1 2026 financial results after market close on May 4, 2026, ensuring timely access to crucial financial information for investors and enhancing market transparency.
- Conference Call Timing: The earnings call is scheduled for May 5, 2026, at 9:00 a.m. Eastern Time, aimed at providing an in-depth discussion of financial performance, thereby improving investor relations management.
- Participation Method: Investors can join the call via webcast or telephone, with advance registration required to obtain dial-in details, ensuring smooth access for participants and enhancing engagement during the call.
- Replay Availability: A replay of the call will be archived on the company's website for at least 30 days post-event, allowing investors who could not attend live to access the information, further increasing the accessibility and transparency of corporate communications.
See More
HealthStream's Virsys12 Recognized as Leader in IDC MarketScape for Provider Data Management
- Market Leadership: HealthStream's Virsys12 has been recognized as a Leader in the IDC MarketScape 2025-2026 U.S. Provider Data Management Vendor Assessment, indicating its outstanding performance and market recognition in provider data management solutions.
- Innovative Solutions: The V12 Enterprise Suite from Virsys12 offers payers and health plans innovative provider data management tools that cover onboarding, credentialing, and network management, enhancing operational efficiency and data accuracy.
- Data Quality Monitoring: The suite provides real-time visibility and data quality dashboards that help payers identify duplicate records and outdated information, thereby optimizing data governance and compliance while enhancing customer experience.
- Strategic Acquisition Impact: Virsys12 was acquired by HealthStream in 2025, further strengthening its position within the healthcare ecosystem and driving automation and continuous data monitoring in provider operations, thereby enhancing market competitiveness.
See More
HealthStream Approves New Share Repurchase Program
- Repurchase Program Scale: HealthStream's Board of Directors has approved a new share repurchase program allowing the company to buy back up to $10 million of common stock, aimed at enhancing shareholder value and reflecting confidence in its stock.
- Flexible Repurchase Methods: The repurchases may be conducted through open market transactions, privately negotiated deals, or other means, demonstrating the company's adaptability to market conditions and liquidity considerations.
- Defined Repurchase Timeline: The repurchase program will terminate on September 12, 2026, or when the maximum dollar amount is reached, ensuring financial flexibility while not mandating the acquisition of any specific number of shares.
- Market Risk Advisory: The company cautions investors that the repurchase program is subject to various factors including market conditions, liquidity, and cash flow, emphasizing the uncertainties surrounding future outcomes and advising investors to exercise caution regarding forward-looking statements.
See More
HealthStream Approves $10 Million Share Repurchase Program
- Repurchase Program Approval: HealthStream announced the approval of a new share repurchase program allowing the company to buy back up to $10 million of its outstanding common stock, aimed at enhancing shareholder value and boosting market confidence.
- Market Execution Method: Under this program, share repurchases will be made occasionally in the open market, indicating the company's confidence in its stock while potentially providing short-term support for the share price.
- Financial Performance Beats Expectations: HealthStream reported a non-GAAP EPS of $0.18, beating expectations by $0.01, and revenue of $79.7 million, exceeding forecasts by $3.49 million, demonstrating strong performance in revenue growth and profitability.
- Future Outlook: The company has set a revenue target of $323 million to $330 million for 2026, reflecting its strategic commitment to advancing its AI-enabled platform and ecosystem, which is expected to further drive business growth.
See More
HEALTHSTREAM INTRODUCES SHARE BUYBACK INITIATIVE
Program Announcement: HealthStream has announced a new Share Repurchase Program aimed at enhancing shareholder value.
Repurchase Details: The program allows for the repurchase of up to $50 million of the company's common stock over a specified period.
Strategic Intent: This initiative reflects HealthStream's commitment to returning capital to shareholders and optimizing its capital structure.
Market Impact: The announcement is expected to positively influence investor confidence and potentially boost the company's stock price.
See More
HealthStream Reports Q4 2025 Earnings with Strong Growth and Strategic Acquisitions
- Significant Revenue Growth: HealthStream reported Q4 2025 revenues of $79.7 million, reflecting a 7.4% year-over-year increase, with subscription product revenues rising by $5.8 million, indicating strong market performance and heightened customer demand.
- Adjusted EBITDA Improvement: The adjusted EBITDA reached $18.8 million, up 16.4% year-over-year, despite operating income declining by 48.8% to $2.4 million, showcasing the company's solid profitability and effective cost management.
- Acquisitions and Share Buyback: The company completed two acquisitions in 2025, namely Virsys12 and MissionCare Collective, and initiated a $10 million share repurchase program in November, reflecting confidence in future growth and flexibility in capital allocation.
- Optimistic 2026 Outlook: Management projects 2026 revenues between $323 million and $330 million, with net income expected between $20.4 million and $22.8 million, indicating a positive outlook on market demand and a strategic plan for sustained growth.
See More
HealthStream Schedules Q1 2026 Earnings Call and Webcast
- Earnings Release Schedule: HealthStream will release its Q1 2026 financial results after market close on May 4, 2026, ensuring timely access to crucial financial information for investors and enhancing market transparency.
- Conference Call Timing: The earnings call is scheduled for May 5, 2026, at 9:00 a.m. Eastern Time, aimed at providing an in-depth discussion of financial performance, thereby improving investor relations management.
- Participation Method: Investors can join the call via webcast or telephone, with advance registration required to obtain dial-in details, ensuring smooth access for participants and enhancing engagement during the call.
- Replay Availability: A replay of the call will be archived on the company's website for at least 30 days post-event, allowing investors who could not attend live to access the information, further increasing the accessibility and transparency of corporate communications.
See More
HealthStream's Virsys12 Recognized as Leader in IDC MarketScape for Provider Data Management
- Market Leadership: HealthStream's Virsys12 has been recognized as a Leader in the IDC MarketScape 2025-2026 U.S. Provider Data Management Vendor Assessment, indicating its outstanding performance and market recognition in provider data management solutions.
- Innovative Solutions: The V12 Enterprise Suite from Virsys12 offers payers and health plans innovative provider data management tools that cover onboarding, credentialing, and network management, enhancing operational efficiency and data accuracy.
- Data Quality Monitoring: The suite provides real-time visibility and data quality dashboards that help payers identify duplicate records and outdated information, thereby optimizing data governance and compliance while enhancing customer experience.
- Strategic Acquisition Impact: Virsys12 was acquired by HealthStream in 2025, further strengthening its position within the healthcare ecosystem and driving automation and continuous data monitoring in provider operations, thereby enhancing market competitiveness.
See More
HealthStream Approves New Share Repurchase Program
- Repurchase Program Scale: HealthStream's Board of Directors has approved a new share repurchase program allowing the company to buy back up to $10 million of common stock, aimed at enhancing shareholder value and reflecting confidence in its stock.
- Flexible Repurchase Methods: The repurchases may be conducted through open market transactions, privately negotiated deals, or other means, demonstrating the company's adaptability to market conditions and liquidity considerations.
- Defined Repurchase Timeline: The repurchase program will terminate on September 12, 2026, or when the maximum dollar amount is reached, ensuring financial flexibility while not mandating the acquisition of any specific number of shares.
- Market Risk Advisory: The company cautions investors that the repurchase program is subject to various factors including market conditions, liquidity, and cash flow, emphasizing the uncertainties surrounding future outcomes and advising investors to exercise caution regarding forward-looking statements.
See More
HealthStream Approves $10 Million Share Repurchase Program
- Repurchase Program Approval: HealthStream announced the approval of a new share repurchase program allowing the company to buy back up to $10 million of its outstanding common stock, aimed at enhancing shareholder value and boosting market confidence.
- Market Execution Method: Under this program, share repurchases will be made occasionally in the open market, indicating the company's confidence in its stock while potentially providing short-term support for the share price.
- Financial Performance Beats Expectations: HealthStream reported a non-GAAP EPS of $0.18, beating expectations by $0.01, and revenue of $79.7 million, exceeding forecasts by $3.49 million, demonstrating strong performance in revenue growth and profitability.
- Future Outlook: The company has set a revenue target of $323 million to $330 million for 2026, reflecting its strategic commitment to advancing its AI-enabled platform and ecosystem, which is expected to further drive business growth.
See More
HEALTHSTREAM INTRODUCES SHARE BUYBACK INITIATIVE
Program Announcement: HealthStream has announced a new Share Repurchase Program aimed at enhancing shareholder value.
Repurchase Details: The program allows for the repurchase of up to $50 million of the company's common stock over a specified period.
Strategic Intent: This initiative reflects HealthStream's commitment to returning capital to shareholders and optimizing its capital structure.
Market Impact: The announcement is expected to positively influence investor confidence and potentially boost the company's stock price.
See More
HealthStream Reports Q4 2025 Earnings with Strong Growth and Strategic Acquisitions
- Significant Revenue Growth: HealthStream reported Q4 2025 revenues of $79.7 million, reflecting a 7.4% year-over-year increase, with subscription product revenues rising by $5.8 million, indicating strong market performance and heightened customer demand.
- Adjusted EBITDA Improvement: The adjusted EBITDA reached $18.8 million, up 16.4% year-over-year, despite operating income declining by 48.8% to $2.4 million, showcasing the company's solid profitability and effective cost management.
- Acquisitions and Share Buyback: The company completed two acquisitions in 2025, namely Virsys12 and MissionCare Collective, and initiated a $10 million share repurchase program in November, reflecting confidence in future growth and flexibility in capital allocation.
- Optimistic 2026 Outlook: Management projects 2026 revenues between $323 million and $330 million, with net income expected between $20.4 million and $22.8 million, indicating a positive outlook on market demand and a strategic plan for sustained growth.
See More
